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Due to non-existing or limited surveillance in Africa, 
little is known about the epidemiology of dengue ill-
ness in the continent. Serological and virological 
data obtained from returning European travellers is a 
key complement to this often flawed information. In 
the past years, dengue 3 virus has emerged in West 
Africa and has been detected in travellers returning to 
Europe. The first dengue epidemic in Cape Verde with 
more than 17,000 cases from September to December 
2009 demonstrated that dengue virus is still expand-
ing worldwide to new territories.
Introduction
Dengue virus is widely distributed in tropical and sub-
tropical countries and is transmitted by day-biting mos-
quitoes of the genus Aedes. It often goes unrecognised 
in African countries, where the lack of surveillance 
systems, or their poor implementation, is the cause of 
missing information on dengue virus activity [1].
Laboratory-based surveillance of dengue virus infec-
tion in febrile travellers could provide useful infor-
mation about the different dengue virus serotypes 
circulating worldwide and in particular those circulat-
ing in areas where limited surveillance is available. 
To this end, the European Network for Imported Viral 
Disease - Collaborative Laboratory Response Network 
(ENIVD-CLRN network) provides outbreak support, in 
particular related to laboratory diagnostics, to assist 
European Union (EU) Member States, candidate coun-
tries and members of the European Economic Area 
and European Free Trade Association (EEA/EFTA) in 
detecting, investigating and responding to outbreak-
prone diseases, imported, rare or unknown infectious 
agents, or outbreaks related to the intentional release 
of pathogens.
A large outbreak of dengue illness with more than 
17,000 cases occurred in the Cape Verde archipelago 
at the end of 2009 [2]. It was the first time that dengue 
virus was detected in the archipelago. Concomitant 
detection of dengue virus in Senegal and identification 
of several imported cases among travellers returning 
from West Africa were reported. This article provides a 
brief review of historic reports of dengue virus in Africa 
focused on West Africa and summarises the recent out-
breaks and the links to imported cases of dengue virus 
infection in Europe.
Dengue virus in West Africa
The burden of dengue virus infection in Africa has not 
been estimated yet. Outbreaks of dengue fever and 
dengue haemorrhagic fever are poorly documented, 
however, we cannot conclude that mild and severe 
dengue infection is infrequent in African countries. The 
circulation of different dengue virus serotypes is also 
poorly documented. Nevertheless some information is 
provided in publications on outbreaks and serosurvey 
studies in Africa and reports involving dengue virus 
infection in travellers. 
A retrospective serological study in 1956 [3] suggests 
that dengue virus caused an epidemic in Durban, South 
Africa in 1927. This report is the first documented den-
gue virus epidemic in Africa. It was not until the end 
of the 1960s, however, that the virus responsible for 
dengue fever outbreaks in Africa could be isolated. 
The first dengue virus (DENV) isolate was DENV-1, 
detected in Nigeria in 1964 [4]. Since then DENV-1, 2 
and 4 have been circulating in West Africa although the 
main serotype reported has been DENV-2 [1]. Viral iso-
lates have been predominantly detected in wild-caught 
mosquitoes (Aedes luteocephalus, Ae. taylori and/or 
Ae. furcifer) involved in sylvatic transmission cycles in 
Senegal and Nigeria, and from a few cases in humans 
who were in contact with forest cycles [5,6]. DENV-2 
from sylvatic cycles have also been isolated in Côte 
d’Ivoire, Burkina Faso and Guinea [5,7,8]. More recently 
in 2005, DENV-2 was identified in a traveller returning 
from Ghana [9]. The last detection of DENV-4 in West 
Africa was in the 1980s in two inhabitants of Dakar, 
Senegal [10]. 
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The first description of DENV-3 activity in Africa was 
related to outbreaks detected during 1984 and 1985 in 
Pemba, Mozambique, with two deaths due to dengue 
haemorrhagic fever [11]. DENV-3 was then detected in 
1993 in Somalia and areas around the Persian Gulf [12]. 
Phylogenetic studies suggested that these outbreaks 
were caused by a virus imported from the Indian sub-
continent [13]. DENV-3 circulation in West Africa was 
first identified in a traveller returning to Spain from 
Cameroon in 2006 and subsequently in a traveller 
returning to Spain from Senegal in 2007 (C. Domingo 
et al., unpublished results). However the first article 
on DENV-3 in West Africa was published in 2008, when 
DENV-3 was detected co-circulating with yellow fever in 
Côte d’Ivoire [14].
Dengue virus importation from Africa into 
Europe
Reports on the importation of dengue virus to Europe 
have been increasing since the 1990s. Some of these 
are publications or reports from single countries or net-
works and show that the frequency of travel-acquired 
dengue virus infections in Africa is low compared to 
south-east Asia and the Americas [15,16]. This distri-
bution is due to two main factors: worldwide dengue 
virus activity and the popularity of certain countries 
as tourist destinations. In a study by the European 
Network on Imported Infectious Disease Surveillance 
(TropNetEurop) covering 481 European travellers 
between 1999 and 2002, 8% of dengue fever cases 
were imported from Africa [17], a proportion similar 
to that found in other European studies. In France, 
between 2002 and 2005, 14% of imported dengue 
fever cases originated in Africa [18]. Ten per cent of 
the cases in Austrian and Finnish travellers were also 
acquired in Africa, as analysed over a 15-year (1990-
2005) and 10-year (1999-2009) period, respectively 
[19,20]. In 2008, dengue virus cases imported from 
Africa reported by TropNetEurop dropped to 4% [21].
Dengue virus importation from 
West Africa (2006-2008) 
In recent years, dengue fever has been documented 
in travellers returning from several West African 
countries, caused in particular by DENV-3 which was 
recently identified in that region (Figure 1). 
From January 2006 to August 2008, 19 imported cases 
of dengue virus infection were reported in travellers 
from West Africa in France: 11 cases from Côte d’Ivoire 
(one in 2006, three in 2007 and seven in 2008), four 
cases in Burkina Faso (one in 2006 and three in 2007), 
two cases in Benin in 2006, one case in Senegal in 2007 
and one case in Mali in 2008 [22]. Dengue serotypes 
detected during this period were DENV-1 in Burkina 
Faso [22], DENV-2 in Côte d’Ivoire [22] and DENV-2 in 
a simultaneous outbreak of chikungunya and dengue 
viruses in Gabon [23], all in 2007. In 2008, DENV-2 
serotype was identified in Mali [14] and in Senegal 
[24]. Moreover, DENV-3 was detected in a Japanese 
tourist and in a French expatriate returning from Côte 
d’Ivoire between May and July 2008 [25]. DENV-3 activ-
ity was also detected in East Africa in 2008 in a Finnish 
traveller returning from Eritrea (O. Vapalahti, personal 
communication).
Recent DENV-3 activity in West Africa
In the beginning of October 2009, a case of den-
gue fever was reported in a Senegalese returning 
to Italy after a holiday in his home country. DENV-3 
infection was diagnosed at the National Institute for 
Infectious Diseases in Rome [26]. At the same time 
France reported DENV-3 in travellers returning from 
Senegal (C. Renaudat, personal communication). Also, 
ProMED posted several archives describing dengue 
virus outbreaks in Senegal: in the Kedoungo region 
[27] and Dakar [28]. The Pasteur Institute in Dakar 
identified DENV-3 in febrile patients (A. Sall, personal 
communication). 
Meanwhile, an unprecedented outbreak has been 
detected in the Cape Verde archipelago in the begin-
ning of September 2009 (week 40) [29]. This is the first 
Figure 1
West African countries where dengue serotypes have been 
identified in recent years (2006-2009)
DENV: dengue virus.
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report of dengue virus activity in that country (Figure 
1). The highest number of cases were reported dur-
ing week 45 (5,512 cases), decreasing in week 47 to 
1,447 cases and finally five cases in week 53. A total of 
17,224 cases including six deaths were reported from 
18 of the 22 municipalities in Cape Verde by the end 
of 2009. The municipality of Praia on Santiago island, 
notified the highest number of cases (13,000 cases) 
followed by Sao Felipe in Fogo Island (3,000 cases) 
[2]. The first samples tested at the Pasteur Institute in 
Dakar confirmed DENV-3 circulation [29]. 
Recently imported DENV-3 cases in Europe and the 
identified outbreaks in West Africa suggest that this 
serotype is spreading in the region.
We used a phylogenetic approach in order to deter-
mine genotype association among the recent DENV-3 
circulating in the region, using sequences provided by 
ENIVD-CLRN laboratories. DENV-3 viruses are divided 
into four geographically different genotypes (I, II, III, 
and IV) [13]. The emergence of a virulent lineage of gen-
otype III in Sri Lanka at the end of 1980s was largely 
associated with a high incidence of the disease and the 
emergence of Dengue haemorrhagic fever in Asia and 
the Americas. All DENV-3 detected in East Africa from 
1984 to 1993 [13] belonged to this lineage of genotype 
III (Figure 2). 
Also, isolates from geographically distant outbreaks, 
strains  ENIVD Spain ex Cameroon 2006, Japan ex Ivory 
Coast 2008 and Saudi Arabia 2004 (Figure 2), and from 
Eritrea in 2008 (not shown in Figure 2; E. Huhtamo 
et al, unpublished results) belong to DENV-3 genotype 
III. The DENV-3 strain that circulated in Senegal in 2009 
and was isolated from a traveller in Italy [26], also 
belonged to genotype III and was closely related to 
the DENV-3 strain circulating in Côte d’Ivoire in 2008. 
Therefore, the DENV-3 that has emerged in the Cape 
Verde archipelago is likely to have been introduced 
from a West African country due to the geographical 
proximity with strong trade and travel activities.
Future outlook 
The recent DENV-3 expansion in West Africa was first 
detected in European travellers returning from this 
area, which triggered the alert for active surveillance 
in the exporting countries.
Figure 2
Phylogenetic tree of DENV-3 sequences
This tree is based on a 139 nt fragment of the E gene. Sequence identification is as follows: country of origin, year of identification. The 
sequences from imported cases are labelled as ENIVD/country of detection/country of exportation/year of detection. Phylogenetic analysis 
was conducting using MEGA 4.0 (Tamura, Dudley, Nei, and Kumar 2007). Genetic distance was calculated with the Tamura Nei algorithm. 
Phylogentic tree was constructed using Neighbor-Joining model and the resultant tree was tested by Bootstrap (1,000 Replicates). Only 
bootstrap probabilities over 60% are shown.
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However, although most of the African countries are 
prepared for surveillance of yellow fever and human 
immunodeficiency virus infections, most of them lack 
specific methods for dengue virus diagnostics and 
require new diagnostic tools. As a recent example of 
such technology transfer, the Pasteur Institute labora-
tories in Paris and Dakar have implemented differen-
tial diagnostics for dengue at the Pasteur Institute in 
Abidjan [14]. This model of cooperation is required also 
in other African countries.
As long as active dengue virus surveillance is poorly 
implemented in Africa, the study of febrile travellers 
returning to Europe could help to detect viral activity 
on the African continent.
As part of the ENIVD-CLRN, a collaborative study on 
imported chikungunya and dengue virus infections in 
European travellers will start in 2010. The aim of the 
study is to complete the global map of chikungunya 
and dengue virus circulation, including the global dis-
tribution of viral genotypes of those viruses. It will per-
mit clinicians to compare the clinical symptoms, signs 
and analytical data of imported cases in Europe. The 
surveillance of travellers returning to Europe will con-
tinue to improve our knowledge about dengue virus 
distribution in Africa.
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